| Stage | XYL | % of rev | GRC | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $2.2B | 100.00% | $193M | 100.00% | XYL ×11.39 |
| Gross profit | $907M | 41.21% | $65M | 33.39% | XYL +7.8pp |
| Operating income | $385M | 17.49% | $34M | 17.54% | GRC +0.1pp |
| Pre-tax income | $365M | 16.58% | $30M | 15.44% | XYL +1.1pp |
| Net income | $288M | 13.08% | $23M | 11.75% | XYL +1.3pp |
| Stage | XYL | GRC | Gap · A − B |
|---|---|---|---|
| Revenue | $2.2B100.00% | $193M100.00% | XYL ×11.39 |
| Gross profit | 41.21%$907M | 33.39%$65M | XYL +7.8pp |
| Operating income | 17.49%$385M | 17.54%$34M | GRC +0.1pp |
| Pre-tax income | 16.58%$365M | 15.44%$30M | XYL +1.1pp |
| Net income |
| 13.08%$288M |
| 11.75%$23M |
| XYL +1.3pp |
No disclosed counterparties: XYL, GRC.